These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26558943)

  • 1. AKT as Locus of Cancer Positive Loops Conversion and Chemotherapy.
    Radisavljevic Z
    Crit Rev Eukaryot Gene Expr; 2015; 25(3):199-202. PubMed ID: 26558943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT as locus of cancer phenotype.
    Radisavljevic Z
    J Cell Biochem; 2015 Jan; 116(1):1-5. PubMed ID: 25164873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKT as Locus of Cancer Unknown Primary Site.
    Radisavljevic Z
    J Cell Biochem; 2016 May; 117(5):1066-8. PubMed ID: 26566181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT as locus of cancer positive feedback loops and extreme robustness.
    Radisavljevic Z
    J Cell Physiol; 2013 Mar; 228(3):522-4. PubMed ID: 22833426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT as locus of cancer multidrug resistance and fragility.
    Radisavljevic Z
    J Cell Physiol; 2013 Apr; 228(4):671-4. PubMed ID: 22886615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT as locus of cancer angiogenic robustness and fragility.
    Radisavljevic Z
    J Cell Physiol; 2013 Jan; 228(1):21-4. PubMed ID: 22585603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT as Locus of Hydrogen Bond Network in Cancer.
    Radisavljevic Z
    J Cell Biochem; 2018 Jan; 119(1):130-133. PubMed ID: 28590011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosome AKT Targeting in Metastatic Cancer.
    Radisavljevic Z
    Crit Rev Eukaryot Gene Expr; 2020; 30(2):121-123. PubMed ID: 32558491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser Disrupts AKT Hydrogen Network in Cancer.
    Radisavljevic Z
    Crit Rev Eukaryot Gene Expr; 2020; 30(4):369-375. PubMed ID: 32894666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muon disrupts AKT hydrogen bond network in cancer.
    Radisavljevic Z
    J Cell Physiol; 2019 Jun; 234(6):7994-7998. PubMed ID: 30317599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT as locus of fragility in robust cancer system.
    Radisavljevic Z
    J Cell Biochem; 2008 Aug; 104(6):2071-7. PubMed ID: 18425770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K and AKT: Unfaithful Partners in Cancer.
    Faes S; Dormond O
    Int J Mol Sci; 2015 Sep; 16(9):21138-52. PubMed ID: 26404259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy.
    Sathe A; Chalaud G; Oppolzer I; Wong KY; von Busch M; Schmid SC; Tong Z; Retz M; Gschwend JE; Schulz WA; Nawroth R
    PLoS One; 2018; 13(1):e0190854. PubMed ID: 29357370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and Analysis of Gab1 Mediated Feedback Loops to Understand Gab's Role in Erk-Akt Signaling and Cancer
    Arkun Y
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():2939-2942. PubMed ID: 31946506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
    Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
    Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective on AKT 25-plus years after its discovery.
    Paraskevopoulou MD; Tsichlis PN
    Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
    Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
    Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosome activates AKT inducing cancer and metastasis.
    Radisavljevic Z
    J Cell Biochem; 2019 Aug; 120(8):12123-12127. PubMed ID: 31021471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways.
    Chen XG; Liu F; Song XF; Wang ZH; Dong ZQ; Hu ZQ; Lan RZ; Guan W; Zhou TG; Xu XM; Lei H; Ye ZQ; Peng EJ; Du LH; Zhuang QY
    Mol Carcinog; 2010 Jun; 49(6):603-10. PubMed ID: 20512842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Akt kinase to modulate survival, invasiveness and drug resistance of cancer cells.
    Cassinelli G; Zuco V; Gatti L; Lanzi C; Zaffaroni N; Colombo D; Perego P
    Curr Med Chem; 2013; 20(15):1923-45. PubMed ID: 23410153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.